Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

NCT02083666 ↗

Phase 1 Terminated 24 enrolled Swedish Orphan Biovitrum Richmond Pharmacology Limited · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The main purpose of this study is to assess the safety and tolerability of SOBI002 in healthy volunteers following single and repeated administration.

Timeline

Start: 2013-12
Primary completion: 2014-11
Completion: 2015-02

Outcome

Outcome not reported

Stopped: “Transient adverse events observed”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SOBI002	Unknown	—	Subcutaneous

Indications

No indication recorded.